Low Sensitivity of International Classification of Diseases, Tenth Revision Coding for Culture-Confirmed Candidemia Cases in an Active Surveillance System: United States, 2019-2020.

Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE

Original Publication: Cary, NC : Published by Oxford University Press on behalf of the Infectious Diseases Society of America, [2014]-

We evaluated healthcare facility use of International Classification of Diseases, Tenth Revision (ICD-10) codes for culture-confirmed candidemia cases detected by active public health surveillance during 2019-2020. Most cases (56%) did not receive a candidiasis code, suggesting that studies relying on ICD-10 codes likely underestimate disease burden.
Competing Interests: Potential conflicts of interest. Christopher A. Czaja reports institutional support from Centers for Disease Control and Prevention cooperative agreements. Helen Johnston reports institutional support from the Centers for Disease Control and Prevention via the Emerging Infections Program cooperative agreement. Paula Clogher reports institutional support from the Centers for Disease Control and Prevention via the Emerging Infections Program cooperative agreement. Monica M. Farley reports institutional support from the Centers for Disease Control and Prevention via the Emerging Infections Program cooperative agreement, NIH/DMID grant to institution (unrelated to this project) and Centers for Disease Control and Prevention Foundation Grant to institution (unrelated to this project). Lee H. Harrison reports support for attending meetings and/or travel from GSK, Sanofi, Merck, Pfizer and Participation on a Data Safety Monitoring Board or Advisory Board (Merck). Sarah Shrum Davis reports institutional support from the Centers for Disease Control and Prevention via the Emerging Infections Program cooperative agreement. Erin C. Phipps reports institutional support from the Centers for Disease Control and Prevention. Brenda L. Tesini reports personal book writing honoraria from Merck. Rebecca Pierce reports institutional support from Centers for Disease Control and Prevention cooperative agreements. William Schaffner reports institutional support from the Centers for Disease Control and Prevention via the Emerging Infections Program cooperative agreement, consulting fees from VBI Vaccines outside the submitted work, and serves as Medical Director for National Foundation for Infectious Diseases outside the submitted work. All other authors report no conflicts of interest. All authors have completed the ICMJE Form for Disclosure of Potential Conflicts of Interest.
(Published by Oxford University Press on behalf of Infectious Diseases Society of America 2022.)

Open Forum Infect Dis. 2022 Mar 23;9(4):ofac097. (PMID: 35350173)
Clin Microbiol Rev. 2007 Jan;20(1):133-63. (PMID: 17223626)
Clin Infect Dis. 2013 May;56(9):1284-92. (PMID: 23315320)
Clin Infect Dis. 2020 Dec 3;71(9):e449-e453. (PMID: 32107534)
MMWR Surveill Summ. 2019 Sep 27;68(8):1-15. (PMID: 31557145)
Emerg Infect Dis. 2016 Jan;23(1):7-13. (PMID: 27983497)
Am J Health Syst Pharm. 2003 Nov 1;60(21 Suppl 6):S11-4. (PMID: 14619128)
Open Forum Infect Dis. 2022 Apr 21;9(7):ofac215. (PMID: 35794945)
PLoS One. 2020 Sep 9;15(9):e0238889. (PMID: 32903280)
N Engl J Med. 2014 May 1;370(18):1673-6. (PMID: 24738642)
JAMA. 2020 Dec 22;324(24):2553-2554. (PMID: 33351033)
JAMA. 2012 Apr 4;307(13):1433-5. (PMID: 22474208)
N Engl J Med. 2018 Nov 1;379(18):1732-1744. (PMID: 30380384)

Keywords: candidemia; candidiasis; international classification of diseases; public health surveillance; sepsis

Date Created: 20221005 Latest Revision: 20221007

20231215

PMC9522671

10.1093/ofid/ofac461

36196298